Study of various aspects of cancer, focusing on discovering new therapeutic intervention.
Novel allosteric regulation in cyclophilins, a target of the Xanthomonas citri
LNBio research suggests a negative ADAM17 regulation by thioredoxin-1 (Trx-1).
Diagnostic kit using immunochromatographic device to detect etiological agents of diarrhea
LNBio project investigates the inactivation of molecular targets that are important for the immunosuppressive phenotype of Treg, by using RNAi.
The Center for Drug Discovery and Development follows a model in which the drug is discovered at a research facility and further developed by the industry.